Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $6.10 $80.02 Wednesday, 19th Apr 2023 CLVS stock ended at $0.151. During the day the stock fluctuated 0% from a day low at $0.151 to a day high of $0.151.
90 days $71.43 $25.28
52 weeks $0.340 $25.28

Historical Clovis Oncology prices

Date Open High Low Close Volume
Dec 08, 2016 $38.82 $38.82 $36.58 $37.34 1 084 320
Dec 07, 2016 $38.77 $39.40 $35.65 $38.41 1 876 208
Dec 06, 2016 $36.93 $40.30 $36.51 $39.48 2 201 942
Dec 05, 2016 $36.50 $37.35 $35.79 $37.24 913 515
Dec 02, 2016 $35.51 $36.88 $35.35 $36.03 955 509
Dec 01, 2016 $34.32 $36.53 $34.27 $35.56 1 717 849
Nov 30, 2016 $35.74 $36.69 $34.11 $34.27 1 762 765
Nov 29, 2016 $34.54 $36.45 $34.16 $35.62 2 046 543
Nov 28, 2016 $37.15 $37.19 $34.04 $34.39 1 822 523
Nov 25, 2016 $36.94 $37.47 $36.08 $37.38 522 538
Nov 23, 2016 $33.97 $36.87 $33.23 $36.79 1 217 341
Nov 22, 2016 $36.30 $36.65 $34.47 $34.78 1 105 904
Nov 21, 2016 $35.73 $37.15 $35.41 $36.31 984 323
Nov 18, 2016 $36.36 $36.73 $35.23 $35.73 1 116 466
Nov 17, 2016 $35.06 $36.83 $34.21 $36.30 1 886 664
Nov 16, 2016 $35.26 $36.09 $34.73 $34.90 864 563
Nov 15, 2016 $34.90 $36.00 $34.30 $35.66 1 314 307
Nov 14, 2016 $34.07 $35.85 $34.02 $35.50 1 718 600
Nov 11, 2016 $32.34 $34.07 $31.64 $33.98 1 897 349
Nov 10, 2016 $33.00 $33.50 $31.23 $32.50 2 375 713
Nov 09, 2016 $28.75 $33.31 $28.17 $32.20 3 849 477
Nov 08, 2016 $27.09 $27.79 $26.58 $27.36 1 870 042
Nov 07, 2016 $27.75 $27.83 $26.96 $27.38 1 512 300
Nov 04, 2016 $26.26 $27.30 $25.81 $27.10 1 627 300
Nov 03, 2016 $27.99 $28.53 $25.81 $25.90 2 517 900
Click to get the best stock tips daily for free!

About Clovis Oncology

Clovis Oncology Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer, as well as for metastatic castration-resistant prostate cancer. In Europe, the... CLVS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT